Vizual Stocks works best vertically on mobile.
VizualStocks APIOperating KPI and segment definitions available for Johnson & Johnson (JNJ) through the VizualStocks API.
Sales generated by Johnson & Johnson companies in the Asia-Pacific and Africa region across both Innovative Medicine and MedTech. This is one of J&J's four geographic sales regions and includes currency-translation effects in reported growth.
asiaPacificAndAfricaRevenueSales generated by Johnson & Johnson companies in Europe across both Innovative Medicine and MedTech. Reported changes include currency translation, which J&J separately removes when discussing operational growth.
europeRevenueProfit from Johnson & Johnson's Innovative Medicine pharmaceutical business after product costs, selling expenses, research and development, and other segment items, but before income tax. It excludes interest and general corporate income or expense that J&J does not allocate to its segments.
innovativeMedicineIncomeBeforeTaxSales from Johnson & Johnson's prescription medicines, including its oncology, immunology, neuroscience, cardiovascular, pulmonary-hypertension and infectious-disease portfolio. This is the larger of J&J's two reportable segments following the separation of Kenvue.
innovativeMedicineRevenueProfit from Johnson & Johnson's MedTech business after product costs, selling expenses, research and development, and other segment items, but before income tax. It excludes interest and general corporate income or expense that J&J does not allocate to its segments.
medTechIncomeBeforeTaxSales from Johnson & Johnson's medical-device portfolio spanning interventional solutions, orthopaedics, surgery and vision. The segment earns revenue from products used by hospitals, clinicians and patients rather than from J&J's prescription medicines.
medTechRevenueNet income or expense that Johnson & Johnson does not allocate to Innovative Medicine or MedTech, used to reconcile the two segments' income before tax to the consolidated total. It includes interest and general corporate items and can also reflect company-level litigation or separation-related charges.
otherIncomeBeforeTaxReconciliationSales generated by Johnson & Johnson's U.S. companies across both Innovative Medicine and MedTech. Unlike the international regions, reported U.S. sales are not affected by translating foreign currencies into dollars.
unitedStatesRevenueSales generated by Johnson & Johnson companies in the Western Hemisphere outside the United States across both Innovative Medicine and MedTech. J&J reports this region separately from the U.S., Europe, and Asia-Pacific and Africa.
westernHemisphereExcludingUnitedStatesRevenueRevenue outside Johnson & Johnson's current Innovative Medicine and MedTech segments, principally the former Consumer Health business in historical periods. The metric falls to zero after Consumer Health was separated as Kenvue and J&J became a two-segment company.
otherRevenue